Netupitant and Palonosetron Hydrochloride in Preventing Chemotherapy Induced Nausea and Vomiting in Patients With Cancer Undergoing BEAM Conditioning Regimen Before Stem Cell Transplant
Clinical trial NCT03097588 · COMPLETED
Trial details
- NCT number
- NCT03097588
- Sponsor
- OHSU Knight Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-27
- Primary completion
- 2020-02-20
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.